Please login to view this media
- Talk
- 29/09/2024
- UK
BOOS/BESS Joint Session: Introduction by Professor Tom Cosker
Description
This presentation from BOA 2024 starts with a warm welcome from Tom Cosker, introducing the joint session of the British Orthopedic Oncology Society and the British Elbow and Shoulder Surgeon Society. The session lasts for 90 minutes and includes four speakers discussing complex cases at the intersection of orthopedic oncology and upper limb surgery.
Professor Cosker provides an introduction to the role of tumor units in England and Wales, emphasizing the importance of referrals for patients with unusual findings in fracture clinics. He stresses the need for vigilance regarding possible primary bone tumors and metastases, urging healthcare professionals to consider the implications of various presentations in their diagnoses and treatment decisions.
Throughout the talk, Professor Coska discusses the challenges faced in identifying and treating bone sarcomas and metastatic disease. He highlights the common types of bone metastases, the importance of obtaining tissue samples, and the need for interdisciplinary collaboration to optimize patient care.
The presentation references specific case studies, illustrating surgical procedures and the complexities of dealing with bone lesions, adverse effects from prior treatments, and patient outcomes. Professor Cosker details surgical techniques, potential complications, and innovative approaches, such as using free fibula grafts to facilitate reconstruction.
Additionally, he touches upon advancements in surgical implants and techniques aimed at improving patient outcomes while cautioning against the risks of dislocations and the importance of understanding surgical anatomy to enhance the likelihood of successful rehabilitation.
In conclusion, Professor Cosker invites audience participation in discussing case studies, fostering an interactive environment focused on refining clinical decision-making and enhancing the quality of care for patients with orthopedic oncology needs.